NASDAQ
No price data available for this timeframe.
AnaptysBio, Inc. (ANAB) has a free cash flow growth of -126.47% as of Friday, May 29, 2026. This represents a 269.28% decrease compared to its 12-month average of 74.71%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.